WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 2.6600
- -0.0700-2.56%
Close Feb 25 16:00 ET
- 2.6400
- -0.0200-0.75%
Post 20:01 ET
179.78MMarket Cap-1.79P/E (TTM)
2.7500High2.6350Low324.19KVolume2.7300Open2.7300Pre Close870.39KTurnover0.67%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.55P/B127.94MFloat Cap2.360052wk Low--Dividend TTM48.10MShs Float85.0000Historical High--Div YieldTTM4.21%Amplitude0.0300Historical Low2.6840Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. Spoor
MarketAMEX
Employees119
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. Spoor
- Director and Chief Executive Officer
- 1.46M
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Juan Graham
- Chief Financial Officer
- --
- Jonathan R. Hunt
- Chief Accounting Officer
- 1.17M
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Robert Froman Willian, III
- Independent Director
- 320.06K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025